Is HARVARD BIOSCIENCE INC (HBIO) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 180.9% / 30% | 16.7% / 30% | 60.4% / 30% | 2.38% / 5% | ✗ NOT HALAL |
| DJIM | 180.9% / 33% | 16.7% / 33% | 60.4% / 33% | 2.38% / 5% | ✗ NOT HALAL |
| MSCI | 35.1% / 33% | 3.2% / 33% | 11.7% / 33% | 2.38% / 5% | ✗ NOT HALAL |
| S&P | 180.9% / 33% | 16.7% / 33% | 60.4% / 33% | 2.38% / 5% | ✗ NOT HALAL |
| FTSE | 35.1% / 33% | 3.2% / 33% | 11.7% / 50% | 2.38% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 57.7% | |
| Operating Margin | 14.0% | |
| Net Margin | -65.5% | |
| Return on Equity (ROE) | -147.1% | |
| Return on Assets (ROA) | 0.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $1M |
| Free Cash Flow | -$2M |
| Total Debt | $44M |
| Debt-to-Equity | 322.4 |
| Current Ratio | 2.2 |
| Total Assets | $127M |
Price & Trading
| Last Close | $5.07 |
| 50-Day MA | $5.47 |
| 200-Day MA | $5.40 |
| Avg Volume | 48K |
| Beta | 1.4 |
|
52-Week Range
$2.80
| |
About HARVARD BIOSCIENCE INC (HBIO)
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is HARVARD BIOSCIENCE INC (HBIO) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), HARVARD BIOSCIENCE INC is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is HARVARD BIOSCIENCE INC's debt ratio?
HARVARD BIOSCIENCE INC's debt ratio is 180.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 35.1%.
What are HARVARD BIOSCIENCE INC's key financial metrics?
HARVARD BIOSCIENCE INC has a market capitalization of $22M, and revenue of $94M. The company maintains a gross margin of 57.7% and a net margin of -65.5%. Return on equity stands at -147.1%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.